JP2024511119A5 - - Google Patents

Info

Publication number
JP2024511119A5
JP2024511119A5 JP2023558526A JP2023558526A JP2024511119A5 JP 2024511119 A5 JP2024511119 A5 JP 2024511119A5 JP 2023558526 A JP2023558526 A JP 2023558526A JP 2023558526 A JP2023558526 A JP 2023558526A JP 2024511119 A5 JP2024511119 A5 JP 2024511119A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
amino acid
synthetic polypeptide
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023558526A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024511119A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/021391 external-priority patent/WO2022204185A1/en
Publication of JP2024511119A publication Critical patent/JP2024511119A/ja
Publication of JP2024511119A5 publication Critical patent/JP2024511119A5/ja
Pending legal-status Critical Current

Links

JP2023558526A 2021-03-22 2022-03-22 修飾されたペプチド模倣薬および使用方法 Pending JP2024511119A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163164132P 2021-03-22 2021-03-22
US63/164,132 2021-03-22
PCT/US2022/021391 WO2022204185A1 (en) 2021-03-22 2022-03-22 Modified peptidomimetics and methods of use

Publications (2)

Publication Number Publication Date
JP2024511119A JP2024511119A (ja) 2024-03-12
JP2024511119A5 true JP2024511119A5 (https=) 2025-09-18

Family

ID=83397833

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023558526A Pending JP2024511119A (ja) 2021-03-22 2022-03-22 修飾されたペプチド模倣薬および使用方法

Country Status (5)

Country Link
US (1) US20240182523A1 (https=)
EP (1) EP4314010A4 (https=)
JP (1) JP2024511119A (https=)
AU (1) AU2022242811A1 (https=)
WO (1) WO2022204185A1 (https=)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3023787A1 (de) 1980-06-25 1982-01-21 Studiengesellschaft Kohle mbH, 4330 Mülheim Verfahren zur erhoehung der inkorporation und der expression von genetischem material in die kerne von intakten zellen mit hilfe von liposomen
US4501729A (en) 1982-12-13 1985-02-26 Research Corporation Aerosolized amiloride treatment of retained pulmonary secretions
US5354844A (en) 1989-03-16 1994-10-11 Boehringer Ingelheim International Gmbh Protein-polycation conjugates
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
EP0452457B1 (en) 1989-11-03 1997-08-20 Vanderbilt University Method of in vivo delivery of functioning foreign genes
FR2715847B1 (fr) 1994-02-08 1996-04-12 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
FR2730637B1 (fr) 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
ES2150832B1 (es) 1996-06-12 2001-06-16 Fichtel & Sachs Ag Dispositivo de maniobra para la maniobra, en particular maniobra neumatica, de un embrague de friccion.
EP0931158A1 (en) 1996-09-06 1999-07-28 The Trustees Of The University Of Pennsylvania An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
EP2655646A4 (en) * 2010-12-20 2014-05-21 Du Pont TARGETED PERHYDROLASES
EP2760463B1 (en) * 2011-09-20 2018-11-21 The University of North Carolina At Chapel Hill Regulation of sodium channels by plunc proteins
US10894811B2 (en) * 2016-02-22 2021-01-19 The University Of North Carolina At Chapel Hill Peptide inhibitors of calcium channels
CN106749679A (zh) * 2017-01-10 2017-05-31 中国人民解放军疾病预防控制所 抗P选择素单链抗体靶向抑制物融合蛋白ScFv‑SPLUNC1及其表达方法与应用

Similar Documents

Publication Publication Date Title
US12162948B2 (en) Methods of engineering transferrin receptor binding polypeptides
JP2009521911A5 (https=)
JP2025032107A (ja) 結核菌シャペロニン６０．１ペプチドおよびその使用
EP4151658A1 (en) Single domain binding molecule
JP5780600B2 (ja) 先天免疫を調節することによる感染の処置および予防を含む、免疫関連疾患障害の処置および予防のための新規ペプチド
JP2024532294A5 (https=)
KR20160011621A (ko) 재조합 인간 분비글로빈에 대한 개선된 사용 방법
RU2010141916A (ru) Растворимый мутант рецептора фактора некроза опухоли
JP2024511119A5 (https=)
Vogen et al. Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylation
JP3135262B2 (ja) ヒトのガラニン、ヒトのガラニンをエンコードするｃＤ ＮＡクローンとヒトのガラニン製造方法
RU2017104284A (ru) Выделенные полипептиды cd44 и их применение
RU2503684C2 (ru) Иммуномодулирующие олигопептиды
Badgery-Parker et al. Receptor binding profile of neuropeptide γ and its fragments: Comparison with the nonmammalian peptides carassin and ranakinin at three mammalian tachykinin receptors
EP0942982A1 (en) Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof
JP2015515855A5 (https=)
JP2023549476A5 (https=)
CN105254719A (zh) 金黄色葡萄球菌trap蛋白的cd4+t细胞表位鉴定及其重组表位疫苗
US20250114430A1 (en) Modified peptidomimetics and methods of use
US20240182523A1 (en) Modified peptidomimetics and methods of use
WO2003025001A1 (en) Multiple antigen peptides (map) as antidotes against snake neurotoxin intoxication
WO2024235270A1 (zh) 补体抑制剂及其制备方法和用途
WO2023154841A2 (en) Sars-cov-2 neutralizing synthetic proteins
JP2023156353A5 (https=)
AU2011253771A1 (en) Method for inhibiting immune complex formation in a subject